Cable Car Capital’s Oruka Therapeutics ORKA Stock Holding History

Cable Car Capital’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.81M	Sell	200,000 -200,000	-50%	-$6.95M	3.39%	6
2025 Q4	$12.1M	Sell	400,000 -100,000	-20%	-$2.79M	0.4%	16
2025 Q3	$9.62M	Sell	500,000 -100,000	-17%	-$1.48M	4.12%	4
2025 Q2	$6.73M	Buy	600,000 +150,000	+33%	+$1.56M	2.16%	5
2025 Q1	$4.62M	Buy	450,000 +116,629	+35%	+$1.45M	5.24%	8
2024 Q4	$6.46M	Hold	333,371	–	–	0.25%	37
2024 Q3	$8.17M	Hold	333,371	–	–	8.73%	1
2024 Q2	$15.3M	Hold	333,371	–	–	16.14%	1
2024 Q1	$7.04M	Hold	333,371	–	–	9.73%	1
2023 Q4	$6.8M	Buy	+333,371	New	+$7.49M	7.06%	4

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Cable Car Capital's ORKA Position: Q1 2026 in Review

Cable Car Capital reduced its Oruka Therapeutics (ORKA) stake by 50% in Q1 2026, selling an estimated $6.95M and leaving 200,000 shares worth $9.81M. The position accounts for 3.39% of the portfolio, ranked #6.

Cable Car Capital first reported a position in ORKA in Q4 2023 and has held it in 10 quarters since. The position peaked at $15.3M in Q2 2024. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

Cable Car Capital held 200,000 shares of Oruka Therapeutics worth $9.81M as of Q1 2026.
Cable Car Capital sold 200,000 Oruka Therapeutics shares in Q1 2026, an estimated $6.95M.
Oruka Therapeutics made up 3.39% of Cable Car Capital's portfolio in Q1 2026, its #6 holding.
Cable Car Capital first reported a position in Oruka Therapeutics in Q4 2023 and has held it in 10 quarters since.
Cable Car Capital's Oruka Therapeutics position peaked at $15.3M in Q2 2024.
184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Cable Car Capital's 13F filing for Q1 2026, filed 15 May 2026.